Life360 director sells 4,000 shares under 10b5-1 plan
Life360, Inc. director John Philip Coghlan reported pre-planned sales of a total of 4,000 shares of common stock on August 3, 2026 by the John Coghlan Living Trust under a Rule 10b5-1 trading plan adopted on December 8, 2025.
Rhea-AI Filing Summary
Life360, Inc. director John Philip Coghlan reported pre-planned sales of a total of 4,000 shares of common stock on August 3, 2026 by the John Coghlan Living Trust under a Rule 10b5-1 trading plan adopted on December 8, 2025. The trust sold 1,400 shares at a weighted average price of $54.66 (range $53.83–$54.80) and 2,600 shares at a weighted average price of $54.90 (range $54.89–$54.95). After these transactions, Coghlan holds 5,676 shares directly, including 4,840 restricted stock units, and 55,494 shares indirectly through a 2025 Grantor Retained Annuity Trust.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common stock F1, F2 | 1,400 | $54.66 | $77K |
| Sale | Common stock F1, F3 | 2,600 | $54.90 | $143K |
| holding | Common stock F4 | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (4)
- F1. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 8, 2025. The Rule 10b5-1 trading plan is a pre-arranged written trading plan pursuant to which shares of the Issuer's common stock are sold automatically based on a predetermined formula that was established by the Reporting Person at a time when the Reporting Person was not aware of any material nonpublic information about the Company.
- F2. The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $53.83 to $54.80, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.
- F3. The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $54.89 to $54.95, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.
- F4. Includes 4,840 restricted stock units, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.
Key Figures
Key Terms
Rule 10b5-1 trading plan regulatory
weighted average price financial
restricted stock units financial
Grantor Retained Annuity Trust financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Life360 (LIF) report for John Philip Coghlan?
Were the Life360 (LIF) insider sales made under a Rule 10b5-1 plan?
What is the nature of the restricted stock units reported for Life360 (LIF)?
AI-generated analysis. How Rhea-AI works. Not financial advice.